Rosenberg Matthew Hamilton Moderna, Inc. Transaction History

Rosenberg Matthew Hamilton

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$69.51 - $104.43 $4,518 - $6,787	-65 Reduced 13.77%	407 $40,000
Q3 2023 Oct 11, 2023	SELL	$96.41 - $126.61 $8,869 - $11,648	-92 Reduced 16.31%	472 $48,000
Q1 2023 Apr 17, 2023	BUY	$135.66 - $197.02 $4,748 - $6,895	35 Added 6.62%	564 $86,000
Q2 2022 Jul 15, 2022	BUY	$117.13 - $176.59 $15,461 - $23,309	132 Added 33.25%	529 $79,000
Q1 2022 Apr 14, 2022	BUY	$126.46 - $235.05 $28,074 - $52,181	222 Added 126.86%	397 $68,000
Q4 2021 Jan 20, 2022	BUY	$225.82 - $368.51 $39,518 - $64,489	175 New	175 $44,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Rosenberg Matthew Hamilton, based on Form 13F filings with the SEC.

Stay updated on Rosenberg Matthew Hamilton with notifications on news.